-
Diagnostic accuracy of VIDISCA-NGS in patients with suspected central nervous system infections
van Zeggeren, I. E., Edridge, A. W. D., van de Beek, D., Deijs, M., Koekkoek, S. M., Wolthers, K. C., van der Hoek, L. & Brouwer, M. C., Apr 2021, In: Clinical microbiology and infection. 27, 4, p. 631.e7-631.e12Research output: Contribution to journal › Article* › Academic › peer-review
-
Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’ (J Hepatol 2019; 71(1): 14-24) (Journal of Hepatology (2019) 71(1) (14–24), (S016882781930128X), (10.1016/j.jhep.2019.02.013))
Merat, S. J., Bru, C., van de Berg, D., Molenkamp, R., Tarr, A. W., Koekkoek, S., Kootstra, N. A., Prins, M., Ball, J. K., Bakker, A. Q., de Jong, M. D., Spits, H., Beaumont, T. & Schinkel, J., Oct 2020, In: Journal of hepatology. 73, 4, p. 999-1000 2 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Optimized hepatitis C virus (HCV) e2 glycoproteins and their immunogenicity in combination with MVA-HCV
Marín, M. Q., Sliepen, K., García-Arriaza, J., Koekkoek, S. M., Pérez, P., Sorzano, C. Ó. S., Gómez, C. E., Sanders, R. W. & Esteban, M., 1 Sept 2020, In: Vaccines. 8, 3, p. 1-25 25 p., 440.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
